TrialHuman vaccines & immunotherapeutics2014

A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.

Karl-Heinz Herbinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.